Rituximab induced Thrombocytopenia in a Systemic Lupus Erythematosus patient
Saptaparna Dasgupta, Bennett University Rituximab being a revolutionary monoclonal antibody, owing up to the mode of action as a potent therapeutic in targeting CD20 cells, has a strong impact on autoimmune health, including systemic lupus erythematosus. Thrombocytopenia, a rare illness, following rituximab is seen to give rise to haematological malignancy. As autoimmune disorders are rare […]